These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21083127)

  • 21. Metabolite quantitation: detector technology and MIST implications.
    Wright P; Miao Z; Shilliday B
    Bioanalysis; 2009 Jul; 1(4):831-45. PubMed ID: 21083141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A new interpretation for "Knockout Drops" (menghan)].
    Fang X; Tao X
    Zhonghua Yi Shi Za Zhi; 2001 Oct; 31(4):210-2. PubMed ID: 11877129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Magic bullets, chemical gagging, controlled risks? On the research of the network "Pharmaceuticals in the 20th century" of the German Research Foundation (DFG)].
    Balz V; Bürgi M; Eschenbruch N; Hulverscheidt M
    Medizinhist J; 2008; 43(2):183-201. PubMed ID: 18839933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolites in safety testing.
    Robison TW; Jacobs A
    Bioanalysis; 2009 Oct; 1(7):1193-200. PubMed ID: 21083045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The scientific contribution of clinical pharmacology.
    Dollery CT
    Eur J Clin Pharmacol; 2008 Feb; 64(2):99-106. PubMed ID: 18172626
    [No Abstract]   [Full Text] [Related]  

  • 26. Historical images of the drug market--LX. [Continued regularly].
    Helfand WH
    Pharm Hist; 1998; 40(4):147. PubMed ID: 11623626
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluorescence fluctuation spectroscopy: a coming of age story.
    Van Orden A; Fogarty K; Jung J
    Appl Spectrosc; 2004 May; 58(5):122A-137A. PubMed ID: 15165323
    [No Abstract]   [Full Text] [Related]  

  • 28. Interpretation and considerations on the safety evaluation of human drug metabolites.
    Atrakchi AH
    Chem Res Toxicol; 2009 Jul; 22(7):1217-20. PubMed ID: 19563206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Galenique: the adventure of a word].
    Poisson J
    J Pharm Belg; 2004; 59(4):105-10. PubMed ID: 15719827
    [No Abstract]   [Full Text] [Related]  

  • 30. A personal perspective on Dr. Paul Janssen.
    Black J
    J Med Chem; 2005 Mar; 48(6):1687-8. PubMed ID: 15771410
    [No Abstract]   [Full Text] [Related]  

  • 31. The evolution of synthetic oral drug properties.
    Proudfoot JR
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1087-90. PubMed ID: 15686918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Andromachus, Galen, Dalibour, Sydenham...: eponyms, as witnesses of an history of the respective galenicals].
    Ledermann F
    J Pharm Belg; 2004; 59(4):111-9. PubMed ID: 15719828
    [No Abstract]   [Full Text] [Related]  

  • 33. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation.
    Daemmrich A
    Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740
    [No Abstract]   [Full Text] [Related]  

  • 34. Best practices in a tiered approach to metabolite quantification: views and recommendations of the European Bioanalysis Forum.
    Timmerman P; Anders Kall M; Gordon B; Laakso S; Freisleben A; Hucker R
    Bioanalysis; 2010 Jul; 2(7):1185-94. PubMed ID: 21083233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment.
    Smith DA; Obach RS
    Chem Res Toxicol; 2009 Feb; 22(2):267-79. PubMed ID: 19166333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reflections on errors in neonatology III. The "experienced" years, 1970 to 2000.
    Robertson AF
    J Perinatol; 2003; 23(3):240-9. PubMed ID: 12732863
    [No Abstract]   [Full Text] [Related]  

  • 37. A holistic strategy for characterizing the safety of metabolites through drug discovery and development.
    Walker D; Brady J; Dalvie D; Davis J; Dowty M; Duncan JN; Nedderman A; Obach RS; Wright P
    Chem Res Toxicol; 2009 Oct; 22(10):1653-62. PubMed ID: 19715349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seeking medicine for the soul.
    Aronson SM
    R I Med J (2013); 2013 Jul; 96(7):11-2. PubMed ID: 23819133
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolites in safety testing: metabolite identification strategies in discovery and development.
    Nedderman AN
    Biopharm Drug Dispos; 2009 May; 30(4):153-62. PubMed ID: 19544286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drugs Bazar of Constantinople].
    Nicolas M
    Rev Hist Pharm (Paris); 2009 Feb; 56(360):495-506. PubMed ID: 19579651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.